Tag: FDA approval

The FDA approved the first oral PCSK9 inhibitor in July 2026. Here is what the approval, trial results, safety findings, and treatment context mean.

View More FDA Approves the First Oral PCSK9 Inhibitor: What the New Cholesterol Option Means